157 related articles for article (PubMed ID: 4592295)
41. [Clinical experiences with Rauwolfia alkaloid raubasin (Lamuran) in arterial, venous and lymphatic circulation disorders].
Brembach H
Med Welt; 1970 Feb; 6():240-3. PubMed ID: 5524036
[No Abstract] [Full Text] [Related]
42. The action of tetranicotinoylfructose in peripheral vascular disease.
Andrews G; Judge TG; Walkey F
Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
[No Abstract] [Full Text] [Related]
43. Inhibition of cGMP-phosphodiesterase-5 by biflavones of Ginkgo biloba.
Dell'Agli M; Galli GV; Bosisio E
Planta Med; 2006 Apr; 72(5):468-70. PubMed ID: 16557462
[TBL] [Abstract][Full Text] [Related]
44. [How to correctly use herbs].
Bonaccorsi A
Assist Inferm Ric; 2007; 26(4):219-26. PubMed ID: 18297986
[No Abstract] [Full Text] [Related]
45. [Prevention of vascular disorders during administration of estroprogestative contraceptives with a medication containing extracts of Ginkgo biloba].
Grasset J; Gauthier R
Phlebologie; 1972; 25(3):269-72. PubMed ID: 4662053
[No Abstract] [Full Text] [Related]
46. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.
Bauer U
Arzneimittelforschung; 1984; 34(6):716-20. PubMed ID: 6386008
[TBL] [Abstract][Full Text] [Related]
47. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Lehrach F; Müller R
Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
[No Abstract] [Full Text] [Related]
48. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
Laveant-Hebrard C; Camus JP
Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
[No Abstract] [Full Text] [Related]
49. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
Dabizzi RP; Fantini F; Cappelli G; Grandonico F
Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
[No Abstract] [Full Text] [Related]
50. [The effect of Vasculat on the peripheral blood circulation and the economy of circulatory function].
Herrwerth E; Brenner L
Med Klin; 1966 Dec; 61(49):1969-71. PubMed ID: 5339977
[No Abstract] [Full Text] [Related]
51. [Medicinal plants useful in the cure of circulatory problems in legs].
Alonso MJ
Rev Enferm; 2005 Mar; 28(3):25-8. PubMed ID: 15871340
[TBL] [Abstract][Full Text] [Related]
52. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
Sideri GC; Fumagalli G; Locatelli R
Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
[No Abstract] [Full Text] [Related]
53. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
Buckert D; Harwart D
Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
[No Abstract] [Full Text] [Related]
54. Vascular diseases: new results with pentoxifylline.
Belcaro G; Cesarone MR; Ippolito E
Angiology; 2002; 53 Suppl 1():1 p following TOC. PubMed ID: 11863316
[No Abstract] [Full Text] [Related]
55. The effects of xanthinol nicotinate on the small blood vessels.
Davis E; Rozov H
Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
[No Abstract] [Full Text] [Related]
56. [Study of the action of Vadilex in the therapy of otologic diseases with vascular components].
Bordes LR
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Jan; 23(1):81-6. PubMed ID: 4278572
[No Abstract] [Full Text] [Related]
57. [Treatment of venous stasis in the lower limbs due to pelvic tumors using aescin].
Tscherne G
Wien Med Wochenschr; 1974 Oct; 124(41):603-5. PubMed ID: 4474744
[No Abstract] [Full Text] [Related]
58. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
Savagnone E; Sunseri V
Minerva Cardioangiol; 1985 Nov; 33(11):757-64. PubMed ID: 4088478
[No Abstract] [Full Text] [Related]
59. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease.
Wang J; Zhou S; Bronks R; Graham J; Myers S
Clin Rehabil; 2007 Jul; 21(7):579-86. PubMed ID: 17702699
[TBL] [Abstract][Full Text] [Related]
60. [Aphthous and ulcerating changes of the mouth mucosa. Treatment with carbenoxolone-sodium].
Wörner H; Rolffs J; Schmelzle R
Fortschr Med; 1974 Jan; 92(2):81-3. PubMed ID: 4594331
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
